Guide showcases how CII empowers organizations to more effectively research, develop, and launch commercially viable products and services TORONTO & LONDON--(BUSINESS WIRE)--#CII--Every year, more than 30,000 new products and services are launched, but l
Technology leader in safety automation adds enhanced customer experience features to help cannabis brands better market their products TORONTO--(BUSINESS WIRE)--TruTrace Technologies (CSE: TTT; OTC: TTTSF), developer of a fully-integrated blockchain plat
MATTHEWS, N.C. & NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--#cGMP--CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market. The partnership will involve an exclusive1 use
SARASOTA, Fla.--(BUSINESS WIRE)--#AMR--Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Jerome Adams, MD, MPH, will serve as a Strategic Healthcare Adviser to Lumos and will be appointed to t
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally,
CALGARY, Alberta--(BUSINESS WIRE)--High Tide Inc. (“High Tide” or the “Company”) (TSXV: HITI) (Nasdaq: HITI) (FSE: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced to
TORONTO--(BUSINESS WIRE)--$CANN--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced it has launched its private label program (“PLP”) that pairs leading brands with Heritage’s well resp
Acquisition expands AbCellera’s existing capabilities to unlock difficult-to-drug transmembrane proteins for antibody discovery programs VANCOUVER, British Columbia & BOSTON--(BUSINESS WIRE)--$ABCL #antibodies--AbCellera (Nasdaq: ABCL), a technology co
Not for distribution to United States newswire services or for dissemination in the United States QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical co
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, the planned oncology spin-off of bluebird bio (NASDAQ: BLUE) announced today that it will host a series of investor events to share further detail on its research pipeline and strategy. Session One: An In
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.